Kei Yamasaki Selected Research

16S Ribosomal RNA

10/2022	Comparative study of bacterial flora in bronchoalveolar lavage fluid of pneumonia patients based on their pneumonia subtypes and comorbidities using 16S ribosomal RNA gene analysis.
4/2022	Combined Radiographic Features and Age Can Distinguish Mycoplasma pneumoniae Pneumonia from Other Bacterial Pneumonias: Analysis Using the 16S rRNA Gene Sequencing Data.
12/2020	Coinfection With Multiple Nontuberculous Mycobacteria as a Possible Exacerbating Factor in Pulmonary Nontuberculous Mycobacteriosis: Clone Library Analysis Using the 16S Ribosomal RNA Gene.
3/2020	Clinical characteristics of patients with bacterial pleuritis in the presence of Streptococcus anginosus group and obligate anaerobes detected by clone library analysis.
1/2017	Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid.
5/2016	The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid.
4/2016	Clinical impact of methicillin-resistant staphylococcus aureus on bacterial pneumonia: cultivation and 16S ribosomal RNA gene analysis of bronchoalveolar lavage fluid.
1/2016	Successful Additional Corticosteroid Treatment in a Patient with Mycoplasma pneumoniae Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid.
7/2015	Possible role of anaerobes in the pathogenesis of nontuberculous mycobacterial infection.
1/2014	An unclassified microorganism: novel pathogen candidate lurking in human airways.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kei Yamasaki Research Topics

Disease

22	Pneumonia (Pneumonitis) 10/2022 - 01/2011
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2011
5	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2014
5	Neoplasms (Cancer) 01/2022 - 09/2013
5	Infections 11/2017 - 01/2011
4	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2014
4	Healthcare-Associated Pneumonia 03/2019 - 10/2013
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2014 - 10/2011
3	Respiratory Insufficiency (Respiratory Failure) 06/2022 - 01/2011
3	Asthma (Bronchial Asthma) 01/2022 - 09/2014
3	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2013
3	Empyema 01/2022 - 01/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2018
2	Bacterial Pneumonia 04/2022 - 04/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2014
2	Tuberculosis (Tuberculoses) 01/2022 - 06/2014
2	Lymphoma (Lymphomas) 01/2022 - 09/2013
2	Rheumatoid Arthritis 01/2022 - 11/2008
2	Dyspnea (Shortness of Breath) 01/2022 - 11/2008
2	Idiopathic Interstitial Pneumonias 01/2022 - 09/2011
2	Invasive Pulmonary Aspergillosis 07/2021 - 10/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2021 - 11/2020
2	Idiopathic Pulmonary Fibrosis 03/2021 - 08/2019
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2011
2	Coinfection 12/2020 - 10/2011
2	Adenocarcinoma 01/2019 - 07/2015
2	Human Influenza (Influenza) 11/2017 - 01/2011
2	Lung Diseases (Lung Disease) 01/2017 - 06/2011
1	Pulmonary Embolism 04/2022
1	Amyopathic dermatomyositis 01/2022
1	Malignant Mesothelioma 01/2022
1	Pleurisy (Pleuritis) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Paragonimiasis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022
1	Merkel Cell Carcinoma 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Polyneuropathies (Polyneuropathy) 05/2021
1	Acute Lung Injury 03/2021
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2021
1	Emphysema 11/2020
1	Thrombosis (Thrombus) 10/2020
1	Papillary Carcinoma 01/2020
1	Blister (Bulla) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020

Drug/Important Bio-Agent (IBA)

13	16S Ribosomal RNAIBA 10/2022 - 01/2011
10	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 01/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 06/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 02/2014
4	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 09/2011
3	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022 - 09/2015
3	AntibodiesIBA 01/2022 - 10/2011
3	Oxygen (Dioxygen)IBA 08/2019 - 01/2011
3	Clarithromycin (Biaxin)FDA LinkGeneric 11/2017 - 01/2012
3	Azithromycin (Zithromax)FDA LinkGeneric 06/2014 - 01/2012
2	AsbestosIBA 01/2022 - 01/2017
2	CollagenIBA 01/2022 - 07/2015
2	liposomal amphotericin B FDA Link 07/2021 - 10/2011
2	Carboplatin (JM8)FDA LinkGeneric 05/2021 - 03/2014
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2020
2	NivolumabIBA 01/2021 - 11/2020
2	Doripenem FDA Link 06/2019 - 03/2016
2	Biological ProductsIBA 07/2015 - 01/2013
2	AntigensIBA 03/2015 - 01/2011
1	AnticoagulantsIBA 04/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Organic Chemicals (Chemicals, Organic)IBA 01/2022
1	SuspensionsIBA 01/2022
1	Serpentine Asbestos (Chrysotile)IBA 01/2022
1	avelumabIBA 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	Local AnestheticsIBA 01/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	PolymersIBA 01/2022
1	acrylic acid (acrylate)IBA 01/2022
1	Formoterol Fumarate (Oxis)FDA Link 11/2021
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2021
1	atezolizumabIBA 05/2021
1	Etoposide (VP 16)FDA LinkGeneric 05/2021
1	Cytotoxins (Cytolysins)IBA 05/2021
1	SmokeIBA 03/2021
1	OzoneIBA 03/2021
1	Nitrogen DioxideIBA 03/2021
1	IpilimumabIBA 01/2021
1	Aquaporin 4IBA 01/2021
1	CobaltIBA 10/2020
1	ChromiumIBA 10/2020
1	GoldIBA 10/2020
1	MetalsIBA 01/2020
1	pembrolizumabIBA 01/2020

Therapy/Procedure

9	Therapeutics 04/2022 - 09/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2014
1	Thoracotomy 01/2022
1	Length of Stay 01/2022
1	Activities of Daily Living (ADL) 01/2022
1	Aftercare (After-Treatment) 05/2021
1	Immunotherapy 01/2021